JASUF yields 8000.00% · JNJ yields 2.13%● Live data
📍 JASUF pulled ahead of the other in Year 1
Combined, JASUF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of JASUF + JNJ for your $10,000?
Jasmine International Public Company Limited provides telecommunications services to individual and corporate clients in Thailand. The company provides high-speed connectivity; Internet services and applications; and software development, distribution, and general software services, including software system that supports value added services for broadband Internet business. It also offers marine and submarine optical fiber maintenance services; international private leased-circuit, Internet protocol virtual private network services, leased line Internet services, managed network services through optic fiber and copper cable networks, National Internet Exchange services, and co-location services and satellite communications. In addition, the company provides data center services; online movie and internet protocol television services; fixed-line services; international calling cards services; wireless communication services through very small aperture terminal; satellite phone services, and small mobile handset and fixed handset for users to use the service from a fixed indoor location in a remote area; and distributes equipment. Further, it engages in system integration, equipment sourcing, system design, and IT systems implementation for government and private sectors; cloud computing; the consultancy, design, and implementation of computer and IT network systems; the provision of space rental services; and investing in telecommunications infrastructure business, other assets, securities, and/or instruments. The company was founded in 1982 and is headquartered in Nonthaburi, Thailand.
Full JASUF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.